Tag: Dr. Nick Kartsonis

Merck bags Recarbrio FDA approval for urinary tract and intra-abdominal infections

pharmanewsdaily- July 17, 2019

Recarbrio FDA approval : Merck & Co. has secured approval from the US Food and Drug Administration (FDA) for its antibacterial drug product Recarbrio (imipenem, ... Read More